Mission
Progress Biotech wishes to develop into a leading player in the global market of Omega-3 fatty acids with a strong focus on quality and service. The company markets innovative high-quality products as a producer of plant-based Omega-3 fatty acids, for the infant formula, food, food supplements and pharmaceutical market sectors.
Progress Biotech wishes to develop into a leading player in the global market of Omega-3 fatty acids with a strong focus on quality and service. The company markets innovative high-quality products as a producer of plant-based Omega-3 fatty acids, for the infant formula, food, food supplements and pharmaceutical market sectors.
Vision
The market for Omega-3 fatty acids originated from traditional, non-sustainable, fish oil products.
The development and demand for such products, in particular, Omega-3 DHA, will increase significantly in the coming years. Increased legislation and customer expectations are driving the need for suppliers capable of supplying such high-quality products and services. This trend applies particularly to non-generic markets, where the demand for products of plant origin, with full traceability through the value chain, and the highest purity, continues to develop strongly worldwide.
The market for fish oil Omega-3 fatty acids will continue to exist, however, with the increasing drive for sustainable vegetable alternatives, new developments with Omega-3 fatty acids will be plant-based. Progress Biotech is well positioned for this development and ready for the future.
The market for Omega-3 fatty acids originated from traditional, non-sustainable, fish oil products.
The development and demand for such products, in particular, Omega-3 DHA, will increase significantly in the coming years. Increased legislation and customer expectations are driving the need for suppliers capable of supplying such high-quality products and services. This trend applies particularly to non-generic markets, where the demand for products of plant origin, with full traceability through the value chain, and the highest purity, continues to develop strongly worldwide.
The market for fish oil Omega-3 fatty acids will continue to exist, however, with the increasing drive for sustainable vegetable alternatives, new developments with Omega-3 fatty acids will be plant-based. Progress Biotech is well positioned for this development and ready for the future.
We are proud to announce that we recently partnered with AAK on our premium plant-based DHA for infant formula. More information
|
Strategy
By entering into strategic relationships with partners selected on the basis of "state of the art" processing techniques, the optimal combination of raw materials and processing is realized for a given product line. This approach helps reduce the need for long development times and capital-intensive investments in production capacity. It also allows Progress Biotech to respond flexibly to developments in product demands and increasing market volumes. By constantly innovating and co-developing products with its partners, Progress Biotech is a true partner rather than simply an ingredient supplier. Full service based on in-depth know-how of the product and full control of the entire supply chain form the basis for long-term relationships with customers and partners. |
